<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Cho EB</submitter><funding>National Research Foundation of Korea</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Clear associations have been found between vitamin D deficiency and several autoimmune diseases including multiple sclerosis (MS). However, the benefits of vitamin D supplementation on disease management remain a matter of debate.&lt;h4>Objective and methods&lt;/h4>Patients with MS (&lt;i>N&lt;/i>=12) and neuromyelitis optica spectrum disorder (NMOSD; &lt;i>N&lt;/i>=12) were enrolled along with 15 healthy controls. Changes in lymphocyte subset proportions during stimulation of their peripheral blood mononuclear cells (PBMCs) with the active form of vitamin D, 1,25-dihydroxyvitamin D&lt;sub>3&lt;/sub> (1,25(OH)&lt;sub>2&lt;/sub>D&lt;sub>3&lt;/sub>), and correlations with serum concentrations of the vitamin D precursor 25-hydroxyvitamin D&lt;sub>3&lt;/sub> (serum 25(OH)D&lt;sub>3&lt;/sub>) were explored. The impact of 1</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>677041</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8358328</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effects of Vitamin D and Dexamethasone on Lymphocyte Proportions and Their Associations With Serum Concentrations of 25-Hydroxyvitamin D&lt;sub>3&lt;/sub> &lt;i>In Vitro&lt;/i> in Patients With Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder.</pubmed_title><pmcid>PMC8358328</pmcid><pubmed_authors>Cho EB</pubmed_authors><pubmed_authors>Kwon S</pubmed_authors><pubmed_authors>Shin JH</pubmed_authors><pubmed_authors>Min JH</pubmed_authors><pubmed_authors>Seok JM</pubmed_authors><pubmed_authors>Kim J</pubmed_authors><pubmed_authors>Kim BJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of Vitamin D and Dexamethasone on Lymphocyte Proportions and Their Associations With Serum Concentrations of 25-Hydroxyvitamin D&lt;sub>3&lt;/sub> &lt;i>In Vitro&lt;/i> in Patients With Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder.</name><description>&lt;h4>Background&lt;/h4>Clear associations have been found between vitamin D deficiency and several autoimmune diseases including multiple sclerosis (MS). However, the benefits of vitamin D supplementation on disease management remain a matter of debate.&lt;h4>Objective and methods&lt;/h4>Patients with MS (&lt;i>N&lt;/i>=12) and neuromyelitis optica spectrum disorder (NMOSD; &lt;i>N&lt;/i>=12) were enrolled along with 15 healthy controls. Changes in lymphocyte subset proportions during stimulation of their peripheral blood mononuclear cells (PBMCs) with the active form of vitamin D, 1,25-dihydroxyvitamin D&lt;sub>3&lt;/sub> (1,25(OH)&lt;sub>2&lt;/sub>D&lt;sub>3&lt;/sub>), and correlations with serum concentrations of the vitamin D precursor 25-hydroxyvitamin D&lt;sub>3&lt;/sub> (serum 25(OH)D&lt;sub>3&lt;/sub>) were explored. The impact of 1</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-05T15:08:48.787Z</modification><creation>2022-02-11T07:18:34.325Z</creation></dates><accession>S-EPMC8358328</accession><cross_references><pubmed>34394078</pubmed><doi>10.3389/fimmu.2021.677041</doi></cross_references></HashMap>